We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+13.67%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.05B
AUM Growth
+$166M
Cap. Flow
-$17.6M
Cap. Flow %
-0.86%
Top 10 Hldgs %
45.48%
Holding
45
New
3
Increased
11
Reduced
25
Closed
3

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$51M
2
NVDA icon
NVIDIA
NVDA
+$43.9M
3
SDRL icon
Seadrill
SDRL
+$10.8M
4
KOS icon
Kosmos Energy
KOS
+$10.1M
5
FBTC icon
Fidelity Wise Origin Bitcoin Fund
FBTC
+$5.38M

Top Sells

Rank Stock Value
1
EXPE icon
Expedia Group
EXPE
+$29.3M
2
CLF icon
Cleveland-Cliffs
CLF
+$21M
3
OMF icon
OneMain Financial
OMF
+$13.6M
4
AMZN icon
Amazon
AMZN
+$13.1M
5
META icon
Meta Platforms (Facebook)
META
+$10.4M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 31.39%
2 Financials 23.2%
3 Communication Services 12.05%
4 Energy 10.1%
5 Healthcare 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
26
Royalty Pharma
RPRX
$25.3B
$43.1M 2.1%
1,419,818
+165,038
+13% +$4.87M
COF icon
27
Capital One
COF
$133B
$37.6M 1.83%
252,467
-69,425
-22% -$9.4M
FISV
28
Fiserv Inc
FISV
$28B
$37.3M 1.82%
233,445
-23,234
-9% -$3.38M
UBER icon
29
Uber
UBER
$153B
$36.5M 1.77%
473,467
-108,266
-19% -$7.77M
ILMN icon
30
Illumina
ILMN
$28.3B
$33.7M 1.64%
252,155
+4,738
+2% +$635K
WAL icon
31
Western Alliance Bancorporation
WAL
$8.93B
$28.9M 1.41%
450,891
-5,992
-1% -$368K
SOFI icon
32
SoFi Technologies
SOFI
$23.6B
$27.5M 1.34%
3,760,597
-15,945
-0.4% -$127K
PTON icon
33
Peloton Interactive
PTON
$2.44B
$26.3M 1.28%
6,135,576
-60,709
-1% -$300K
PGEN icon
34
Precigen
PGEN
$2.59B
$25.3M 1.23%
17,453,455
+1,469,755
+9% +$2.11M
EXE
35
Expand Energy Corp
EXE
$21.5B
$24.3M 1.18%
273,385
-326
-0.1% -$26.2K
FBTC icon
36
Fidelity Wise Origin Bitcoin Fund
FBTC
$12.1B
$6.98M 0.34%
+112,401
New +$5.38M
RKT icon
37
Rocket Companies
RKT
$38.6B
$2.08M 0.1%
142,791
-213,886
-60% -$2.65M
LEN.B icon
38
Lennar Class B
LEN.B
$20.8B
$1.93M 0.09%
13,150
– –
TEVA icon
39
Teva Pharmaceuticals
TEVA
$41.1B
$1.41M 0.07%
100,000
– –
VNT icon
40
Vontier
VNT
$4.94B
$1.36M 0.07%
30,000
-10,000
-25% -$390K
BRLT icon
41
Brilliant Earth
BRLT
$20.2M
$748K 0.04%
250,000
– –
FANG icon
42
Diamondback Energy
FANG
$52.4B
$595K 0.03%
3,000
-7,000
-70% -$1.19M
CLF icon
43
Cleveland-Cliffs
CLF
$6.99B
– –
-1,027,036
Closed -$21M
SPY icon
44
State Street SPDR S&P 500 ETF Trust
SPY
$822B
– –
-2,091
Closed -$994K
KRTX
45
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
– –
-11,631
Closed -$3.68M
1
2

Similar funds

CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Patient Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Patient Capital Management held 45 positions worth $2.05B, up 8.8% from $1.89B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Patient Capital Management's Q1 2024 filing shows 3 new, 11 increased, 25 reduced and 3 closed positions. Its largest new stake was Biogen: 217,887 shares worth $47M. The largest sale was Expedia Group, an estimated $29.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, down from 34% a quarter earlier, followed by Financials and Communication Services.

  • Patient Capital Management's largest Q1 2024 buy was Biogen: 217,887 shares worth $47M.
  • Patient Capital Management added most to Seadrill in Q1 2024, an estimated $10.8M increase.
  • Patient Capital Management's biggest Q1 2024 reduction was Expedia Group, cutting an estimated $29.3M.
  • Patient Capital Management fully exited Cleveland-Cliffs in Q1 2024, selling an estimated $21M.
  • Patient Capital Management's ten largest holdings make up 45% of its $2.05B portfolio in Q1 2024.
  • Patient Capital Management opened 3 new positions and closed 3 in Q1 2024.
  • Patient Capital Management's portfolio value rose 8.8% quarter-over-quarter to $2.05B.

Based on Patient Capital Management's 13F filing for Q1 2024, filed 15 May 2024.